U.S. needs master protocols such as U.K.’s RECOVERY to speed COVID-19 evidence collection, McClellan says: a BioCentury audio interview

The establishment of clinical trial protocols for COVID-19 in the U.S. that emulate the U.K. RECOVERY trial — a streamlined protocol that facilitates participation by community hospitals and has generated data quickly — is imperative, according to Mark McClellan, director of the Duke-Margolis Center for Health Policy.

McClellan, a former FDA commissioner and CMS administrator, noted that “among the things that we've learned so far that really matter in COVID outcomes, especially for seriously ill patients, a lot of it has come from [the] RECOVERY trial.” ...